Aging is a process of growing old or maturing including a reduction in strength, endurance, speed of reaction, agility, basal metabolism, sexual activity and hearing acuity. The bones are more brittle, the skin drier and less elastic and the teeth are shed. Ageing effects (e.g., patchy hyper-pigmentation, fine wrinkles, telangiectasias) result from intrinsic and extrinsic processes and reflect the physical effects of the passage of time. Ageing skin is usually associated with a sagging face, in which deeper tissues (i.e., subjacent soft tissue) and structural landmarks lose their resiliency.
Anti-aging Products and Therapies predominantly moisturiser-based cosmeceutical skin care products marketed with the promise of making the consumer look younger by reducing, masking or preventing signs of skin aging.
The market has been precisely categorized and segmented and further sub classified for understanding and procuring in-depth, logical, analytical and comprehensive analysis.
The Global Anti-aging Products and Therapies market has been thoroughly scrutinized and then carefully demarcated by geographic locations which are based on major economic regions and their topographical regions. Growing competition and the changing market dynamics has been highlighted. Aggressive market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio and recent developments. The Market share and Market size prominent players for 2015 are profiled in this report.
The report contains the most detailed and in-depth segmentation and analysis of the Global Anti-aging Products and Therapies Market during the forecast period 2015 – 2020.
“1. Anti-aging Products and Therapies Market Overview
2. Executive summary
3. Anti-aging Products and Therapies Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. Patent Analysis
3.2.3. Top 5 Financials Analysis
4. Anti-aging Products and Therapies Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Anti-aging Products and Therapies Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunities Analysis
5.3. Product lifecycle
5.4. Pricing Analysis
6. Anti-aging Products and Therapies Market – By Active Ingredient
6.1. Retinol
6.2. Epidermal growth factors
6.3. Peptides
6.4. Alpha Hydroxy Acids (AHA’s)
6.5. Co-enzyme Q10
6.6. Argirelline
6.7. Anti-oxidants
6.8. Sun Protection Factor (SPF)
6.9. Vitamin C
7. Anti-aging Products and Therapies Market – By Products
7.1. Natural
7.2. Multifunctional
7.3. Anti ageing
7.4. Anti – wrinkle
7.5. Anti – stretch marks
7.6. Others
8. Anti-aging Products and Therapies Market – By Therapies and Services
8.1. BOTOX
8.2. Chemical peels
8.3. Injectable skin
8.4. Rejuvenation and dermal fillers
8.5. Hormone replacement therapy
8.6. Telomere based therapy
8.7. Gene therapy
8.7.1. Proteomics
8.7.2. Genomics
8.7.3. Predictive medicine
8.8. Liposuction
8.9. Sclerotherapy
8.10. Hair Restoration Services
8.11. Eye-Lid Surgery
8.12. Abdominoplasty
8.13. Anti-Pigmentation Therapy
8.14. Breast Augmentation
9. Anti-aging Products and Therapies Market – By Devices
9.1. Anti-Cellulite Treatment Devices
9.2. Microderm Abrasion Devices
9.3. Laser Aesthetic Devices
9.4. Radiofrequency Devices
9.5. Others
10. Anti-aging Products and Therapies Market -Geographic Analysis
10.1. North America
10.1.1. Canada
10.1.2. Mexico
10.1.3. USA
10.1.4. Others
10.2. Europe
10.2.1. France
10.2.2. Germany
10.2.3. Italy
10.2.4. Sweden
10.2.5. U.K
10.2.6. Others
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. Australia
10.3.5. Others
10.4. ROW
10.4.1. South Africa
10.4.2. South America
10.4.3. Russia
10.4.4. Saudi Arabia
10.4.5. Others
11. Market Entropy
11.1. New Product Launches
11.2. M&As, Collaborations, JVs and Partnerships
12. Company profiles
12.1. Allergan Inc
12.2. Alberto Culver Company
12.3. Avon Products Inc
12.4. Beiersdorf
12.5. Bio Pharma US Corp
12.6. Bayer Schering Pharma AG
12.7. Chanel SA
12.8. Christian Dior
12.9. Clarins
12.10. Elizabeth Arden Inc
12.11. Ella Bache
12.12. Estee Lauder Inc
12.13. F. Hoffmann-La Roche Ltd
12.14. GlaxoSmithKline Plc
12.15. General Nutrition Centers Inc
12.16. Henkel KgaA
12.17. Jan Marini Skin Research Inc
12.18. Johnson & Johnson
12.19. Janssen Pharmaceutica Products LP
12.20. Neutrogena Corporation
12.21. L’Oréal SA, Merck & Company Inc
12.22. NeoStrata Company Inc
12.23. Novartis International AG
12.24. Orlane SA
12.25. Procter & Gamble
12.26. Revlon Inc
12.27. Robanda International
12.28. Unilever PLC
12.29. Valeant Pharmaceuticals International
12.30. Woodridge Labs Inc
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
“”*Financials would be provided on a best efforts basis for private companies””
13. Appendix
13.1. Abbreviations
13.2. Sources
13.3. Research Methodology
13.4. Bibliography
13.5. Compilation of Expert Insights
13.6. Disclaimer”